CJC-1295 DAC 5mg

(35 to 65 year old demographic)

Discover the Power of CJC-1295 DAC for Advanced Research

CJC-1295 DAC is a cutting-edge peptide designed to mimic the body’s natural Growth Hormone Releasing Hormone (GHRH). This innovative compound is engineered to bind with specific receptors in the pituitary gland, potentially triggering a cascade of biological processes that enhance the secretion and circulation of growth hormones (GH) throughout the body. Preclinical studies have demonstrated that CJC-1295 DAC administration leads to a significant increase in growth hormone levels, making it a valuable tool for scientific research.

How CJC-1295 DAC Works

CJC-1295 DAC operates by closely replicating the structure and function of naturally occurring GHRH. This similarity allows it to effectively bind to GHRH receptors located on cells within the anterior pituitary gland. By stimulating these receptors, CJC-1295 DAC promotes the production and release of growth hormones into the bloodstream. Research indicates that elevated levels of human growth hormone (HGH) can persist for several days following administration, highlighting the peptide’s sustained efficacy.

Extended Half-Life for Prolonged Effects

One of the standout features of CJC-1295 DAC is its extended half-life, which sets it apart from other peptides used in scientific research. This is achieved through its unique Drug Affinity Complex (DAC) technology, which enables the peptide to form stable bonds with albumin in the blood plasma. This bio-conjugation process significantly prolongs its presence in the body, allowing for sustained increases in growth hormone levels over an extended period. Unlike other peptides that degrade quickly, CJC-1295 DAC offers researchers a reliable option for long-term studies.

Indirect Role in IGF-1 Production

In addition to its direct impact on growth hormone release, CJC-1295 DAC plays a critical role in the production of Insulin-like Growth Factor-1 (IGF-1). Once growth hormone is released into the bloodstream, it travels to the liver, where it stimulates the synthesis of IGF-1. Studies have shown that CJC-1295 DAC not only elevates GH levels but also increases IGF-1 concentrations. These two hormones work synergistically to support various biological functions, including cell proliferation and tissue repair.

The Science Behind DAC Technology

The “DAC” in CJC-1295 DAC stands for Drug Affinity Complex, a groundbreaking innovation developed by renowned researcher John J. Kopchick at Ohio University. This technology enhances the peptide’s stability and longevity by allowing it to bind with serum albumin, enabling a slow and steady release over time. This extended activity makes CJC-1295 DAC an ideal choice for research requiring sustained growth hormone stimulation.

CJC-1295 DAC Specifications

• CAS Number: 863288-34-0
• Molecular Formula: C152H252N44O42
• Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys
• Molar Mass: 3367.9 g/mol
• Half-Life: 6-8 days
• Purity: Minimum 98%
• Form: Lyophilized powder in sterile glass vials
• Dosage: 5mg per vial

Storage Instructions: Store reconstituted samples under refrigeration.

Important Disclaimer
CJC-1295 DAC is intended solely for in vitro research purposes and should only be handled by licensed professionals. This product is not approved by the FDA for human or animal consumption and must not be misbranded, misused, or mislabeled as a drug, food, supplement, or cosmetic.

References

1. Activation of the GH/IGF-1 axis by CJC-1295: ScienceDirect
2. Netnography of CJC-1295 use: Taylor & Francis
3. CJC-1295 in GHRH knockout mice: American Journal of Physiology
4. LC-HRMS/MS identification of GHRH: Springer
5. Drug-receptor interactions: NCBI